quinazolines has been researched along with ribose in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sage, CR; Stout, TJ; Stroud, RM | 1 |
Ballard, P; Bradbury, RH; Harris, CS; Hennequin, LF; Hickinson, M; Johnson, PD; Kettle, JG; Klinowska, T; Leach, AG; Morgentin, R; Ogilvie, DJ; Olivier, A; Pass, M; Warin, N; Williams, EJ | 1 |
2 other study(ies) available for quinazolines and ribose
Article | Year |
---|---|
The additivity of substrate fragments in enzyme-ligand binding.
Topics: Crystallography, X-Ray; Deoxyuracil Nucleotides; Deoxyuridine; Escherichia coli; Folic Acid; Models, Molecular; Mutagenesis, Site-Directed; Phosphates; Protein Conformation; Quinazolines; Recombinant Proteins; Ribose; Structure-Activity Relationship; Thymidylate Synthase; Uridine | 1998 |
Inhibitors of epidermal growth factor receptor tyrosine kinase: Novel C-5 substituted anilinoquinazolines designed to target the ribose pocket.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Binding Sites; Cell Proliferation; Colonic Neoplasms; ErbB Receptors; Female; Humans; KB Cells; Mice; Mice, Nude; Molecular Structure; Protein Kinase Inhibitors; Quinazolines; Rats; Ribose; Structure-Activity Relationship; Transplantation, Heterologous; Tumor Cells, Cultured | 2006 |